RubrYc Therapeutics

CDMO makes an AI and drug discovery play in latest, small-time acquisition
Endpoints
Thu, 09/22/22 - 10:11 am
CDMO
artificial intelligence
iBio
drug discovery
RubrYc Therapeutics
oncology